These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1392522)

  • 1. Ultrastructural investigations of the enterochromaffin-like (ECL) cells in three different rat strains (Sprague-Dawley, Fischer 344, Wistar) after treatment with the H+,K(+)-ATPase inhibitor pantoprazole.
    Rohr I; Ockert D; Reznik GK
    Exp Toxicol Pathol; 1992 Aug; 44(4):197-200. PubMed ID: 1392522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the ECL-cell frequency in the stomachs of 3 different rat strains.
    Tuch K; Ockert D; Hauschke D; Christ B
    Pathol Res Pract; 1992 Jun; 188(4-5):672-5. PubMed ID: 1409110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation.
    Bakke I; Qvigstad G; Brenna E; Sandvik AK; Waldum HL
    Acta Physiol Scand; 2000 May; 169(1):29-37. PubMed ID: 10759608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionally impaired, hypertrophic ECL cells accumulate vacuoles and lipofuscin bodies. An ultrastructural study of ECL cells isolated from hypergastrinemic rats.
    Zhao CM; Bakke I; Tostrup-Skogaker N; Waldum HL; Håkanson R; Chen D
    Cell Tissue Res; 2001 Mar; 303(3):415-22. PubMed ID: 11320657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of short-term treatment with an H+,K(+)-ATPase inhibitor (B8301-078) on enterochromaffin-like (ECL) cells in rat fundic mucosa.
    Rohr I; Tuch K
    Toxicol Pathol; 1992; 20(2):141-5. PubMed ID: 1335613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The H+, K(+)-ATPase inhibitor pantoprazole (BY1023/SK&F96022) interacts less with cytochrome P450 than omeprazole and lansoprazole.
    Simon WA; Büdingen C; Fahr S; Kinder B; Koske M
    Biochem Pharmacol; 1991 Jul; 42(2):347-55. PubMed ID: 1650212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuing development of acid pump inhibitors: site of action of pantoprazole.
    Shin JM; Besancon M; Prinz C; Simon A; Sachs G
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():11-23. PubMed ID: 7514042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pantoprazole on 24-h intragastric pH and serum gastrin in humans.
    Londong W
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():39-46. PubMed ID: 8180293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructure of enterochromaffin-like cells in rat stomach: effects of alpha-fluoromethylhistidine-evoked histamine depletion and hypergastrinemia.
    Chen D; Zhao CM; Andersson K; Sundler F; Håkanson R
    Cell Tissue Res; 1996 Mar; 283(3):469-78. PubMed ID: 8593676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in binding properties of two proton pump inhibitors on the gastric H+,K+-ATPase in vivo.
    Shin JM; Sachs G
    Biochem Pharmacol; 2004 Dec; 68(11):2117-27. PubMed ID: 15498502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach.
    Lee H; Håkanson R; Karlsson A; Mattsson H; Sundler F
    Digestion; 1992; 51(3):125-32. PubMed ID: 1355746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage.
    Fornai M; Natale G; Colucci R; Tuccori M; Carazzina G; Antonioli L; Baldi S; Lubrano V; Abramo A; Blandizzi C; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):79-87. PubMed ID: 16080005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (H+,K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 4. A novel series of dimethoxypyridyl-substituted inhibitors with enhanced selectivity. The selection of pantoprazole as a clinical candidate.
    Kohl B; Sturm E; Senn-Bilfinger J; Simon WA; Krüger U; Schaefer H; Rainer G; Figala V; Klemm K
    J Med Chem; 1992 Mar; 35(6):1049-57. PubMed ID: 1313110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrin effects on isolated rat enterochromaffin-like cells in primary culture.
    Prinz C; Scott DR; Hurwitz D; Helander HF; Sachs G
    Am J Physiol; 1994 Oct; 267(4 Pt 1):G663-75. PubMed ID: 7524350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo cytochrome P 450 interactions of the newly developed H+/K(+)-ATPase inhibitor pantoprazole (BY 1023/SK&F 96022) compared to other antiulcer drugs.
    Hanauer G; Graf U; Meissner T
    Methods Find Exp Clin Pharmacol; 1991; 13(1):63-7. PubMed ID: 1651432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat stomach enterochromaffin-like cells are not stimulated by pylorus ligation. A biochemical and ultrastructural study.
    Zhao CM; Chen D; Monstein HJ; Ding XQ; Sundler F; Håkanson R
    Scand J Gastroenterol; 1996 Jan; 31(1):31-7. PubMed ID: 8927937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study.
    Martinsen TC; Skogaker NE; Bendheim MØ; Waldum HL
    Med Electron Microsc; 2003 Mar; 36(1):18-32. PubMed ID: 12658348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
    Postius S; Bräuer U; Kromer W
    Life Sci; 1991; 49(14):1047-52. PubMed ID: 1832475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rabeprazole on histamine synthesis in enterochromaffin-like cells of mast cell-deficient (Ws/Ws) rats.
    Nakamura S; Watanabe H; Yokota T; Matsui H; Onji M; Maeyama K
    Eur J Pharmacol; 2000 Apr; 394(1):9-16. PubMed ID: 10771028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.